Clinical Trial

Heavy Strength Training in Head and Neck Cancer Survivors

Study acronym: LIFTING2
Completed Phase 2
View on ClinicalTrials.gov →
Summary
Despite improvements in treatments, head and neck cancer survivors (HNCS) still endure acute and chronic side effects such as loss of muscular strength, limitations in physical functioning, fatigue, and swallowing difficulties that impact quality of life (QoL) and limit return to work. Light-to-moderate intensity strength training (LMST) has been shown to improve some side effects. Heavy lifting strength training (HLST) may further improve outcomes in some populations, however, only one small pilot study has focused on HNCS. The LIFTING 2 trial will be the first to examine the feasibility and effects of a HLST program versus no exercise in HNCS.
Protocol Amendment History 4 changes
critical Trial completed 2026-08-13
notable Enrollment reduced: 60 -> 37 participants 2026-08-13
notable Primary completion pushed: 2026-06 -> 2026-07-06 2026-08-13
minor Completion pushed: 2026-06 -> 2026-07-06 2026-08-13
Trial Details
NCT Number NCT06289049
Lead Sponsor University of Alberta
Conditions Head and Neck Neoplasms, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Head and Neck Carcinoma
Enrollment 37 participants
Start Date 2025-02-17
Primary Completion 2026-07-06 (estimated)
Study Completion 2026-07-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-12